Our previous study confirmed that sorafenib promotes invasiveness and metastasis of HCC in xenograft models, as indicated by increased intrahepatic metastasis (IHM), lung metastasis, and circulating tumor cells of tumors with higher expression of HTATIP2[12]. Here, HTATIP2 is linked to hepatocellular carcinoma.